Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Scleroderma and Related Disorders 2017-01, Vol.2 (1), p.11-18
Hauptverfasser:	Khanna, Dinesh, Furst, Daniel E., Clements, Philip J., Allanore, Yannick, Baron, Murray, Czirjak, Lazlo, Distler, Oliver, Foeldvari, Ivan, Kuwana, Masataka, Matucci-Cerinic, Marco, Mayes, Maureen, Medsger, Thomas, Merkel, Peter A., Pope, Janet E., Seibold, James R., Steen, Virginia, Stevens, Wendy, Denton, Christopher P.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
ISSN:	2397-1983 2397-1991
DOI:	10.5301/jsrd.5000231